Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.476NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.18SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
CV.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
B.1.476NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
A.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.18ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
CV.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.476NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
CV.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
A.18ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
B.1.476ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CV.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
A.19NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
CV.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.476EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.18ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
CV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.19NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.476ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
CV.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
A.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.476EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
CV.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
A.19NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.476SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.476SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
A.18NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CV.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
A.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.476SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CV.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
A.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CV.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.476ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
A.19NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.476ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
CV.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
A.19NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.476ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
CV.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.484SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
B.1.1.484NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.484NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
A.18NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
DJ.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used